Cargando…
Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001)
BACKGROUND: The blood concentration of S-1 and adverse events are affected by renal function. Herein, an S-1 dosage formula was developed based on renal function, indicating the dose for a target blood concentration. This study aimed to explore the usefulness of the formula in adjuvant chemotherapy...
Autores principales: | Kawakami, Takeshi, Mizusawa, Junki, Hasegawa, Hiroko, Imazeki, Hiroshi, Kano, Kazuki, Sato, Yuya, Iwasa, Satoru, Takiguchi, Shuji, Kurokawa, Yukinori, Doki, Yuichiro, Boku, Narikazu, Yoshikawa, Takaki, Terashima, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587934/ https://www.ncbi.nlm.nih.gov/pubmed/35767198 http://dx.doi.org/10.1007/s10120-022-01315-8 |
Ejemplares similares
-
Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol
por: Makuuchi, Rie, et al.
Publicado: (2023) -
A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508
por: Kurokawa, Yukinori, et al.
Publicado: (2009) -
Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)
por: Tahara, Makoto, et al.
Publicado: (2015) -
Inter-institutional heterogeneity in outcomes of chemotherapy for metastatic gastric cancer: correlative study in the JCOG9912 phase III trial
por: Kurokawa, Y, et al.
Publicado: (2016) -
Impact of COVID-19 on gastric cancer treatment in Japanese high-volume centers: a JCOG stomach cancer study group survey
por: Tokunaga, Masanori, et al.
Publicado: (2021)